Pronóstico del mercado de oncología radioterapéutica en Asia Pacífico hasta 2031: análisis regional, por tipos (radioterapia de haz externo y radioterapia de haz interno) y aplicaciones (cáncer de mama, cáncer de próstata, cáncer de pulmón, cáncer de cabeza y cuello, cáncer de cuello uterino y otros)
Las iniciativas estratégicas en oncología radioterapéutica impulsan el mercado de oncología radioterapéutica de Asia Pacífico
La oncología radioterapéutica tiene un enorme potencial en el tratamiento del cáncer. Además, se espera que la evolución constante de la radioterapia por parte de los actores del mercado en términos de desarrollo de productos, innovación, lanzamiento de productos, aprobación de productos, fusiones, adquisiciones y asociaciones, entre otros, contribuya al crecimiento del mercado. Algunas de las recientes iniciativas estratégicas llevadas a cabo en el mercado son:
- En mayo de 2024, Elekta lanzó su último acelerador lineal (linac), Evo, un CT-Linac con nuevas imágenes mejoradas con IA de alta definición, capaz de brindar radioterapia adaptativa en línea y fuera de línea, así como tratamientos mejorados de radioterapia guiada por imágenes estándar.
- En mayo de 2024, The Icon Group colaboró con Cyberknife Australia Pty Ltd para establecer hasta 6 nuevas clínicas de oncología radioterápica (empresa conjunta propuesta), que brindarán tratamientos de oncología radioterápica utilizando el sistema \'Cyberknife\'.
- En mayo de 2024, GE HealthCare lanzó Revolution RT, una nueva solución de tomografía computarizada (TC) de radioterapia con soluciones innovadoras de hardware y software para ayudar a aumentar la precisión de las imágenes, al tiempo que simplifica el flujo de trabajo de simulación para una experiencia de vía de atención oncológica más personalizada y fluida para médicos y pacientes.
- En abril de 2024, Accuray Incorporated mostró avances en hardware y software diseñados para mejorar la experiencia del tratamiento del cáncer en ESTRO 2024. Las plataformas CyberKnife y Radixact de última generación brindan a los equipos de atención médica la tecnología necesaria para expandir el poder curativo de la radioterapia y cumplir con el enfoque del congreso de este año, cerrando la brecha de atención.
- En septiembre de 2023, MVision AI lanzó la primera solución integral de segmentación basada en pautas (GBS) para un contorno eficaz de la radioterapia. Guide facilita que los equipos clínicos evalúen con precisión las estructuras generadas por IA, lo que les permite refinar sus habilidades de contorno. Verify permite la comparación visual y volumétrica de contornos, lo que facilita que las clínicas observen similitudes y diferencias. La implementación combinada de Guide Verify y Contour+ abarca todas las necesidades clínicas en el contorno de la radioterapia.
Por lo tanto, están surgiendo iniciativas estratégicas entre los actores del mercado que operan en el mercado de la oncología radioterápica, que se espera que amplifiquen el crecimiento del mercado y creen amplias oportunidades para el mercado de la oncología radioterápica.
Resumen del mercado de oncología radioterapéutica en Asia Pacífico
El campo de la oncología radioterapéutica se ha estado desarrollando rápidamente en China debido a importantes avances tecnológicos. Las empresas conjuntas han desempeñado un papel crucial en el aumento de la accesibilidad de los sistemas de oncología radioterapéutica. Con estas iniciativas, las empresas también se centran en el desarrollo de productos de terapia de alta tecnología. China Isotope and Radiation Corporation (CIRC) y Accuray, un desarrollador de sistemas de radioterapia con sede en EE. UU., establecieron una empresa conjunta en enero de 2019. Este proyecto utiliza las soluciones de tratamiento de vanguardia de Accuray y las capacidades de fabricación local para abordar las necesidades insatisfechas en el mercado chino. Tales iniciativas demuestran la dedicación de China al desarrollo de habilidades de oncología radioterapéutica dentro del país, lo que generaría perspectivas notables para el mercado de oncología radioterapéutica en los próximos años.
Ingresos y pronóstico del mercado de oncología radioterapéutica en Asia Pacífico hasta 2031 (millones de USD)
Segmentación del mercado de oncología radioterapéutica en Asia Pacífico
El mercado de oncología radioterapéutica en Asia Pacífico se clasifica en tipos, aplicaciones y países.
Según los tipos, el mercado de oncología radioterápica de Asia Pacífico se bifurca en radioterapia de haz externo y radioterapia de haz interno. El segmento de radioterapia de haz externo tuvo una mayor participación de mercado en 2023.
En términos de aplicación, el mercado de oncología radioterápica de Asia Pacífico se clasifica en cáncer de mama, cáncer de próstata, cáncer de pulmón, cáncer de cabeza y cuello, cáncer de cuello uterino y otros. El segmento de cáncer de mama tuvo la mayor participación de mercado en 2023.
Por país, el mercado de oncología radioterápica de Asia Pacífico está segmentado en China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico. China dominó la participación de mercado de oncología radioterápica de Asia Pacífico en 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd, y Curium son algunas de las empresas líderes que operan en el mercado de oncología radioterapéutica de Asia Pacífico.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Asia Pacific Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Asia Pacific Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Asia Pacific Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Radiation Oncology Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Mevion Medical Systems
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 NTP RADIOISOTOPES
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Mallinckrodt Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Panacea Medical Technologies Pvt. Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Curium
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Radiation Oncology Market Segmentation
Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Mevion Medical Systems.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Panacea Medical Technologies Pvt. Ltd
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.